Toripalimab (anti-PD-1) versus high-dose interferon-α2b as adjuvant therapy in resected mucosal melanoma: a phase II randomized trial-Reference-Cited by-同舟云学术

Toripalimab (anti-PD-1) versus high-dose interferon-α2b as adjuvant therapy in resected mucosal melanoma: a phase II randomized trial

Published:2022-10 Issue:10 Volume:33 Page:1061-1070
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

Lian B.,Si L.,Chi Z.H.,Sheng X.N.,Kong Y.,Wang X.,Tian H.,Li K.,Mao L.L.,Bai X.,Tang B.X.,Yan X.Q.,Li S.M.,Zhou L.,Dai J.,Tang X.W.,Ran F.W.,Yao S.,Guo J.,Cui C.L.

Publisher

Elsevier BV

Subject

Oncology,Hematology

Reference26 articles.

1. Incidence of noncutaneous melanomas in the;McLaughlin;U.S. Cancer,2005

2. The natural history and patterns of metastases from mucosal melanoma: an analysis of 706 prospectively-followed patients;Lian;Ann Oncol,2017

3. Clinical presentation, histology, and prognoses of malignant melanoma in ethnic Chinese: a study of 522 consecutive cases;Chi;BMC Cancer,2011

4. Multifactorial analysis of prognostic factors and survival rates among 706 mucosal melanoma patients;Cui;Ann Surg Oncol,2018

5. Phase II randomized trial comparing high-dose IFN-alpha2b with temozolomide plus cisplatin as systemic adjuvant therapy for resected mucosal melanoma;Lian;Clin Cancer Res,2013

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy and Safety of Postoperative Adjuvant Radiation Therapy in Resected Nasal Cavity and Paranasal Sinus Mucosal Melanoma: A Combined Analysis;International Journal of Radiation Oncology*Biology*Physics;2024-10

2. The risk of endocrine immune-related adverse events induced by PD-1 inhibitors in cancer patients: a systematic review and meta-analysis;Frontiers in Oncology;2024-05-02

3. Primary Cutaneous Melanoma—Management in 2024;Journal of Clinical Medicine;2024-03-11

4. Outcomes of patients with resected stage III/IV acral or mucosal melanoma, treated with adjuvant anti-PD-1 based therapy;European Journal of Cancer;2024-03

5. Immunotherapy for mucosal melanoma;Oncology and Translational Medicine;2023-12